1 citations
,
March 2022 in “Irish Journal of Medical Science” This study suggests that the Gabrin sign and hypertension in male patients are associated with a worse prognosis for COVID-19.
1 citations
,
December 2021 in “Journal of Cosmetic Dermatology” This study observed that COVID-19 is associated with accelerated androgenetic alopecia, and platelet-rich plasma treatment showed improvement in hair loss after infection.
1 citations
,
October 2018 in “PubMed” In a mouse model of infected burns, this study found that treatment with recombinant fusion peptide EK significantly decreased Pseudomonas aeruginosa colony count and improved wound healing rates compared to controls.
August 2026 in “Pharmaceutics” In this study, researchers developed a dexpanthenol-infused nanotechnological platform within hyaluronic acid hydrogels that promoted wound healing in mice by providing a protective barrier and significantly enhancing skin regeneration, including increased fibroblast activity and tissue remodeling.
This study reported that dandelion herb-derived carbon dots significantly enhanced wound healing in mice with Staphylococcus aureus infections, outperforming a commercial wound healing spray through their antibacterial and dual ROS-modulating capabilities.
June 2026 in “ACS Applied Materials & Interfaces” In this study, carbon dots derived from dandelion herb demonstrated significant antibacterial and biofilm-disrupting capabilities, promoting wound healing in a mouse model infected with S. aureus, while also showing excellent biocompatibility and the ability to modulate reactive oxygen species.
January 2026 in “Archives of Dermatological Research” This study found that patients who were hospitalized for COVID-19 were more likely to develop telogen effluvium, a type of hair loss, compared to those treated as outpatients, suggesting a link between COVID-19 severity and this condition.
December 2025 in “Nature Communications” This study demonstrated that skin organoids derived from human stem cells can model cutaneous tuberculosis, revealing that fibrosis development in Mycobacterium tuberculosis-infected organoids is linked to the PI3K-AKT and AP1 pathways in fibroblasts, and suggesting the potential for antifibrotic treatment evaluation.
November 2025 in “Mendeley Data” This study observed that JAK inhibitors were safe and effective for patients with moderate-to-severe alopecia areata and comorbid latent hepatitis B or stable tuberculosis, with careful monitoring and selective prophylaxis.
November 2025 in “Mendeley Data” This study observed that JAK inhibitor therapy may be safely administered to patients with alopecia areata and latent HBV or stable TB, without reactivation of these infections, when appropriate monitoring and prophylaxis are used.
October 2025 in “Journal of Nanobiotechnology” This study reports that using a hydrogel-based therapy that dynamically regulates reactive oxygen species helps achieve skin regeneration in infected wounds, promoting organized dermal architecture with improved hair follicle and blood vessel formation, rather than scar formation.
May 2025 in “International Medical Case Reports Journal” This case report highlights lichen planus pigmentosus in a 60-year-old man, which was linked to previously undetected hepatitis C infection and liver cirrhosis, suggesting a need for hepatitis C testing in patients with similar dermatological manifestations.
December 2024 in “Journal of Investigative Dermatology” People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.
This case report from the study described a 62-year-old woman with pityriasis rubra pilaris and Kaposi's varicelliform eruption, whose skin condition improved significantly with isotretinoin treatment over 43 weeks.
In this study using a mouse model, researchers utilized single-cell RNA sequencing to create a comprehensive cellular atlas of infected versus uninfected wounds, revealing that Enterococcus faecalis infections lead to immunosuppressive changes in skin cells and disrupt normal wound healing processes.
Stem cell therapies, especially adipose-derived ones, show promise for treating severe COVID-19 and related conditions.
September 2023 in “Zenodo (CERN European Organization for Nuclear Research)” This study examined the clinical and radiological features of lung damage in children caused by COVID-19, highlighting the emergence and persistence of both respiratory and extrapulmonary symptoms in these cases.
April 2023 in “Al-Azhar International Medical Journal /Al-Azhar International Medical Journal” This study found a significant association between COVID-19 hospitalizations and acute telogen effluvium in Egyptian women, emphasizing the importance of considering recent COVID-19 infections when evaluating hair loss in this population.
January 2023 in “Zenodo (CERN European Organization for Nuclear Research)” This study reported that olive oil applications on the scalp may regenerate hair loss linked to SARS CoV-2 infection and vaccination, based on observations in two individuals.
This study observed that Egyptian women with a history of COVID-19 infection frequently experienced telogen effluvium, indicating the importance of considering COVID-19 history in patients presenting with hair loss.
November 2022 in “Journal of the Endocrine Society” This case report describes a patient with ectopic Cushing's syndrome who experienced fatal complications from COVID-19, highlighting the challenges in managing such patients due to immune response alterations from endogenous hypercortisolemia.
October 2022 in “Ophthalmic Plastic and Reconstructive Surgery” This case report describes a 7-year-old boy who developed telogen effluvium resulting in unilateral ciliary madarosis nine weeks after COVID-19 infection, with no other causes identified.
September 2022 in “JAAD Case Reports” In this study, researchers observed that approximately 25% of patients experienced hair loss after COVID-19 infection, with nonscarring alopecia being the most common form.
July 2022 in “Journal of Investigative Dermatology” May 2022 in “Brazilian Journal of Health Review” This narrative review explores the potential mechanisms linking telogen effluvium to SARS-CoV-2 infection but reports no new clinical findings.
This study reports that platelet-rich plasma treatments improved hair loss in patients with anagen effluvium following COVID-19 recovery.
May 2017 in “Journal of The American Academy of Dermatology” A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.
November 2006 in “Yafteh” This study found that an herbal drug reduced the duration of telogen effluvium more effectively than minoxidil in patients.
January 2022 in “Mammalian Genome” This study found that the wavy coat trait in Nakano cataract mice is polygenic, involving major and minor genes, and resembles human curly scalp hair associated with the PRSS53 gene alteration.
176 citations
,
June 2016 in “PLoS ONE” In these initial clinical studies, NAP monotherapy showed significant reductions in HBsAg levels among patients with chronic HBV, suggesting potential as part of future combination therapies.